Fig. 3From: Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screeningCorrelations between array fluorescence (FL) intensities and single-parameter immunoassay measurements. Values (transformed to natural logarithms) of lipocalin-2 (LCN2) and matrix metalloproteinase-9 (MMP9) levels in serum samples obtained at baseline, following induction neoadjuvant chemotherapy (post-NACT) and sequential chemoradiotherapy (post-CRT), and at treatment evaluation from 24 randomly chosen patients were comparedBack to article page